Advances in specific immunotherapy of malignant melanoma

Clara N Curiel, Marie France Demierre

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

Management of malignant melanoma continues to present a challenge to dermatologists, particularly in advanced cases. In light of the steady increase in the worldwide incidence and mortality rates for melanoma, better understanding of the immune mechanisms regulating melanoma progression and interaction with the host's immune system seems eminently important. New studies on the role of immune mechanisms in the pathogenesis and clinical course of melanoma have recently been published. We review the immune mechanisms involved in tumor progression and ways in which these mechanisms may be applied toward immunotherapeutic management of malignant melanoma.

Original languageEnglish (US)
Pages (from-to)167-185
Number of pages19
JournalJournal of the American Academy of Dermatology
Volume43
Issue number2 I
StatePublished - 2000
Externally publishedYes

Fingerprint

Immunotherapy
Melanoma
Immune System
Mortality
Incidence
Neoplasms

ASJC Scopus subject areas

  • Dermatology

Cite this

Advances in specific immunotherapy of malignant melanoma. / Curiel, Clara N; Demierre, Marie France.

In: Journal of the American Academy of Dermatology, Vol. 43, No. 2 I, 2000, p. 167-185.

Research output: Contribution to journalArticle

@article{b9c053071f87407295fb2d788a834e23,
title = "Advances in specific immunotherapy of malignant melanoma",
abstract = "Management of malignant melanoma continues to present a challenge to dermatologists, particularly in advanced cases. In light of the steady increase in the worldwide incidence and mortality rates for melanoma, better understanding of the immune mechanisms regulating melanoma progression and interaction with the host's immune system seems eminently important. New studies on the role of immune mechanisms in the pathogenesis and clinical course of melanoma have recently been published. We review the immune mechanisms involved in tumor progression and ways in which these mechanisms may be applied toward immunotherapeutic management of malignant melanoma.",
author = "Curiel, {Clara N} and Demierre, {Marie France}",
year = "2000",
language = "English (US)",
volume = "43",
pages = "167--185",
journal = "Journal of the American Academy of Dermatology",
issn = "0190-9622",
publisher = "Mosby Inc.",
number = "2 I",

}

TY - JOUR

T1 - Advances in specific immunotherapy of malignant melanoma

AU - Curiel, Clara N

AU - Demierre, Marie France

PY - 2000

Y1 - 2000

N2 - Management of malignant melanoma continues to present a challenge to dermatologists, particularly in advanced cases. In light of the steady increase in the worldwide incidence and mortality rates for melanoma, better understanding of the immune mechanisms regulating melanoma progression and interaction with the host's immune system seems eminently important. New studies on the role of immune mechanisms in the pathogenesis and clinical course of melanoma have recently been published. We review the immune mechanisms involved in tumor progression and ways in which these mechanisms may be applied toward immunotherapeutic management of malignant melanoma.

AB - Management of malignant melanoma continues to present a challenge to dermatologists, particularly in advanced cases. In light of the steady increase in the worldwide incidence and mortality rates for melanoma, better understanding of the immune mechanisms regulating melanoma progression and interaction with the host's immune system seems eminently important. New studies on the role of immune mechanisms in the pathogenesis and clinical course of melanoma have recently been published. We review the immune mechanisms involved in tumor progression and ways in which these mechanisms may be applied toward immunotherapeutic management of malignant melanoma.

UR - http://www.scopus.com/inward/record.url?scp=0033856848&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033856848&partnerID=8YFLogxK

M3 - Article

VL - 43

SP - 167

EP - 185

JO - Journal of the American Academy of Dermatology

JF - Journal of the American Academy of Dermatology

SN - 0190-9622

IS - 2 I

ER -